• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Dimethoxybenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Methoxybenzenes Dimethoxybenzenes

Recent Advances in the Application of 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene (CAS: 1700265-02-6) in Chemical and Pharmaceutical Research

1-Bromo-2,6-difluoro-3,5-dimethoxybenzene (CAS: 1700265-02-6) is a halogenated aromatic compound that has recently gained attention in chemical and pharmaceutical research due to its unique structural properties and potential applications in drug discovery and material science. This compound, characterized by its bromo and fluoro substituents on a dimethoxybenzene backbone, serves as a versatile intermediate in organic synthesis, particularly in the development of novel bioactive molecules and advanced materials.

Recent studies have highlighted the role of 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene in the synthesis of complex heterocyclic compounds, which are pivotal in medicinal chemistry. For instance, researchers have utilized this compound as a key building block in the construction of fluorinated analogs of known drug candidates, aiming to enhance their metabolic stability and binding affinity. The presence of both bromine and fluorine atoms allows for selective functionalization, enabling the introduction of diverse pharmacophores into the molecular scaffold.

In a 2023 study published in the Journal of Medicinal Chemistry, scientists demonstrated the utility of 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene in the synthesis of potent kinase inhibitors. The compound was employed in a palladium-catalyzed cross-coupling reaction to introduce a brominated aromatic moiety into the inhibitor's core structure, resulting in improved selectivity against specific kinase targets. This approach underscores the compound's value in the design of next-generation therapeutics for oncology and inflammatory diseases.

Another significant application of 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene lies in its use as a precursor for the development of fluorinated liquid crystals and organic electronic materials. The electron-withdrawing nature of the fluorine atoms, combined with the steric effects of the methoxy groups, imparts unique electronic properties to derivatives of this compound. Recent work in Advanced Materials has shown that such derivatives exhibit promising performance in organic light-emitting diodes (OLEDs) and photovoltaic devices, opening new avenues for sustainable energy technologies.

From a synthetic perspective, the reactivity of 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene has been extensively studied to optimize its use in multi-step transformations. Modern catalytic methods, including photoredox catalysis and C-H activation, have been successfully applied to this substrate, enabling more efficient and environmentally friendly synthetic routes. These advancements not only reduce the environmental footprint of chemical processes but also enhance the scalability of pharmaceutical production.

In conclusion, 1-Bromo-2,6-difluoro-3,5-dimethoxybenzene (CAS: 1700265-02-6) represents a valuable tool in contemporary chemical and pharmaceutical research. Its versatility in organic synthesis, combined with its potential applications in drug development and material science, positions it as a compound of significant interest for future investigations. Ongoing research efforts are expected to further expand its utility, particularly in the design of innovative therapeutics and functional materials.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)